T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
RB Global
RBA
$15.8B
| $7.36M | ﹤0.01% |
124,091
-11
| -0% | -$677 |
|
1452
Sensata Technologies
ST
$6.68B
| $7.32M | ﹤0.01% |
126,348
+4,921
| +4% | +$287K |
|
1453
Syndax Pharmaceuticals
SNDX
$1.72B
| $7.22M | ﹤0.01% |
420,420
-18,597
| -4% | -$341K |
|
1454
Palantir
PLTR
$425B
| $7.17M | ﹤0.01% |
272,181
+120,081
| +79% | +$2.78M |
|
|
VMW
1455
DELISTED
VMware, Inc
VMW
| $7.16M | ﹤0.01% |
44,752
-5,677
| -11% | -$908K |
|
|
FSTX
1456
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $7.11M | ﹤0.01% |
+827,728
| New | +$7.06M |
|
1457
Jones Lang LaSalle
JLL
$17B
| $6.93M | ﹤0.01% |
35,474
+758
| +2% | +$148K |
|
|
ELAT
1458
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $6.86M | ﹤0.01% |
128,175
-11,330
| -8% | -$569K |
|
1459
Grand Canyon Education
LOPE
$3.75B
| $6.69M | ﹤0.01% |
74,314
-203
| -0.3% | -$20.1K |
|
1460
HEICO Corp Class A
HEI.A
$38.1B
| $6.59M | ﹤0.01% |
53,048
-4,763
| -8% | -$602K |
|
1461
Crown Holdings
CCK
$13B
| $6.58M | ﹤0.01% |
64,372
-307,839
| -83% | -$32.5M |
|
|
COHR
1462
DELISTED
Coherent Inc
COHR
| $6.57M | ﹤0.01% |
24,854
-1,814
| -7% | -$477K |
|
1463
loanDepot
LDI
$304M
| $6.47M | ﹤0.01% |
+503,653
| New | +$8.21M |
|
|
RAVN
1464
DELISTED
Raven Industries Inc
RAVN
| $6.42M | ﹤0.01% |
111,048
+612
| +0.6% | +$26.6K |
|
1465
Carlisle Companies
CSL
$14.7B
| $6.42M | ﹤0.01% |
33,543
-2,341
| -7% | -$435K |
|
1466
SolarEdge
SEDG
$2B
| $6.41M | ﹤0.01% |
23,192
-8,116
| -26% | -$2.04M |
|
1467
CALL
State Street Financial Select Sector SPDR ETF
XLF
$59.4B
| $6.24M | ﹤0.01% |
+170,000
| New | +$6.22M |
|
1468
Chegg
CHGG
$88.6M
| $6.21M | ﹤0.01% |
74,746
-125,099
| -63% | -$10.4M |
|
1469
Trinity Capital Inc.
TRIN
$1.72B
| $6.19M | ﹤0.01% |
427,573
+194,000
| +83% | +$2.83M |
|
1470
Pliant Therapeutics
PLRX
$66.3M
| $6.13M | ﹤0.01% |
210,678
-3,479
| -2% | -$108K |
|
1471
Liberty Global Class C
LBTYK
$3.52B
| $6.13M | ﹤0.01% |
226,500
-2,400
| -1% | -$64.7K |
|
1472
OGE Energy
OGE
$9.81B
| $6.05M | ﹤0.01% |
179,752
+3,326
| +2% | +$112K |
|
|
MASI
1473
DELISTED
Masimo
MASI
| $6.03M | ﹤0.01% |
24,868
-3,185
| -11% | -$727K |
|
1474
Eagle Bancorp
EGBN
$878M
| $6.02M | ﹤0.01% |
107,357
+61,674
| +135% | +$3.41M |
|
|
GTM
1475
ZoomInfo Technologies
GTM
$1.2B
| $6M | ﹤0.01% |
114,946
+4,900
| +4% | +$230K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.